Inscopix is a Palo Alto, CA -based neurotechnology company that has developed a miniature microscope platform for in vivo, in life measures of cellular-resolution neural activity during free behavior. Inscopix provides research contract services aimed at integrating the platform into preclinical development programs. As part of these services, the Inscopix platform enables pharmacodynamic readouts from therapeutically targeted circuits and circuit-based efficacy assays in disease models to quickly and efficiently profile and prioritize compounds in development. Together, these capabilities fuel a quantitative, data-driven approach that can significantly accelerate and de-risk preclinical therapeutic development for neuropsychiatric and neurodegenerative disorders.